Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.
The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.
No matter which type of meal you try, though, you'll learn essential cooking skills along the way, such as dicing and ...
Future expansion hinges on integrating digital connectivity with lab-quality sensitivity to solidify decentralized care.
New options for testing and treating some of the most common sexually transmitted diseases are becoming available. In the ...
Adolescents who tested positive for COVID-19 were more likely to report ongoing symptoms lasting at least 4 weeks compared with those who tested negative or never tested. Adolescents aged 12 to 17 ...
Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you need the expertise of a virologist and an immunologist, plus a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results